Insider Profile
Etienvre, Yann Louis
1
Companies Filed At
0
Open-Market Buys (2yr)
—
Buy Value (2yr, open-market)
Dec 13, 2023
Most Recent Trade
11
Credibility
Score
38%
Hit Rate
+13.3%
Avg 90d Return
-14.7%
Median 90d Return
8
Evaluated Trades
+65.5%
Best Trade
-18.8%
Worst Trade
Hit rate and returns are based on 8 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
+53.8%
Median Alpha · 90d
2
Closed Buys Evaluated
100%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
cluster buyer size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 2 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Dec 13, 2023 $CLS
Celestica
— Open Market Buy 29,693 $27.14 $806K 10
Dec 11, 2023 $CLS
Celestica
— Other Sell 35,497 — — 10
Dec 11, 2023 $CLS
Celestica
— Exercise Sell 44,541 — — 10
Dec 11, 2023 $CLS
Celestica
— Open Market Buy 44,541 $27.02 $1.2M 10
Dec 11, 2023 $CLS
Celestica
— Exercise Buy 44,541 $27.02 $1.2M 10
Feb 01, 2023 $CLS
Celestica
— Exercise Buy 9,036 — — 10
Feb 01, 2023 $CLS
Celestica
— Exercise Sell 9,036 — — 10
Feb 01, 2023 $CLS
Celestica
— Other Sell 8,099 — — 10
Jan 31, 2023 $CLS
Celestica
— Comp. Grant Buy 80,063 — — 10
Jan 31, 2023 $CLS
Celestica
— Comp. Grant Buy 53,375 — — 10
Feb 01, 2022 $CLS
Celestica
— Comp. Grant Buy 51,406 — — 10
Feb 01, 2022 $CLS
Celestica
— Comp. Grant Buy 77,108 — — 10
Jan 01, 2022 $CLS
Celestica
— Other Sell — — — 10
Jan 01, 2022 $CLS
Celestica
— Other Sell — — — 10
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.